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Induction of MIF synthesis and secretion by tubular epithelial The renin-angiotensin system (RAS) has been impli-
cells: A novel action of angiotensin II. cated in the pathogenesis of renal damage. Inhibition of
Background. Angiotensin II (Ang II) plays an important the RAS by angiotensin-converting enzyme inhibitorsrole in the development of renal injury through its vasoactive
(ACEI) or angiotensin subtype 1 receptor antagonistsand proinflammatory activities. We investigated whether some
(AT1RA) significantly attenuates the decline in renal func-of the effects of Ang II could be mediated through the produc-
tion of macrophage migration inhibitory factor (MIF). tion associated with diabetic [1, 2] and nondiabetic [3, 4]
Methods. Groups of rats underwent sham surgery (sham), renal diseases. As well as regulating glomerular hyper-
subtotal nephrectomy (STNx), or STNx plus treatment with
tension, angiotensin II (Ang II) has a range of nonhemo-irbesartan. Renal tissue was examined 12 weeks postsurgery
dynamic effects that are important in mediating renalfor MIF mRNA expression and leukocyte accumulation. To
determine whether Ang II had a direct effect on MIF produc- damage.
tion, mRNA synthesis and protein secretion were examined The proinflammatory actions of Ang II, including the
in proximal tubular epithelial (NRK52E and MCT) cell lines. induction of growth factors [5], cytokines [6], chemo-Results. MIF mRNA was strongly expressed in 5.4% 1.1%
kines [7–10], and adhesion molecules [11–15] have been(mean  SD) of cortical tubules of sham-operated rats. This
revealed. Ang II also promotes mononuclear cell recruit-was significantly up-regulated in STNx rats (44.9%  22.6%)
and was abrogated by administration of irbesartan (2.8%  ment and proliferation, as well as increased extracellular
2.4%). STNx resulted in significant glomerular and interstitial matrix (ECM) accumulation and subsequent renal in-
accumulation of macrophages and T cells, which correlated
jury. A pathogenic role of Ang II in immune mediatedwith glomerular and tubular MIF mRNA expression, respec-
renal disease has been demonstrated in two rodent mod-tively. In vitro studies of tubular epithelial cells revealed that
Ang II caused a twofold increase in MIF mRNA expression els: immune complex glomerulonephritis and antiglo-
in NRK52E and MCT cells, which was abrogated by irbesartan. merular basement membrane nephritis [8, 16–18].
In addition, Ang II induced a rapid release of 50% of MIF Glomerular and interstitial macrophage and T-cell ac-protein from NRK52E cells within 20 minutes.
cumulation is a feature of most types of renal diseaseConclusion. This study has demonstrated that Ang II up-
[19] and precedes glomerulosclerosis and renal fibrosis.regulates MIF mRNA production and MIF protein secretion
by tubular epithelial cells. Ang II may promote accumulation The accumulation of macrophages occurs through a pro-
and activation of interstitial leukocytes via induction of MIF cess of recruitment and proliferation of circulating mono-
synthesis and secretion in renal tubular epithelial cells. This
cytes. Macrophage migration inhibitory factor (MIF), amay be an important mechanism by which Ang II mediates
proinflammatory cytokine, is an important regulator ofrenal injury.
macrophage accumulation at sites of tissue injury [20].
MIF, a 12.5 kD protein, was originally described as a
lymphocyte product able to inhibit macrophage migra-
tion and regulate the delayed-type hypersensitivity re-
sponse [21, 22]. Since this original description, it is known
Key words: MIF, angiotensin, subtotal nephrectomy. that MIF is a unique molecule that regulates inflamma-
tion [23], cell proliferation [24], differentiation [25], and
Received for publication May 8, 2002
angiogenesis [26]. MIF is up-regulated in glomerular andand in revised form September 20, 2002, and October 16, 2002
Accepted for publication November 21, 2002 tubular epithelial cells in human proliferative glomerulo-
nephritis and renal transplant rejection, where the de- 2003 by the International Society of Nephrology
1265
Rice et al: Angiotensin induces MIF synthesis and secretion1266
gree of up-regulation corresponds to histologic damage ment of rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and a cloned 441 bp of rat MIF were linearizedand loss of renal function [20, 27]. In the diseased kidney,
and digoxigenin (DIG)-labeled using T7-RNA polymeraseinfiltrating macrophages and T cells express MIF, but
to produce cRNA sense or antisense probes for Northernthe renal parenchymal cells are the major site of MIF
Blotting and in situ hybridization according to the manu-expression [20, 28]. The pathogenic role of MIF has been
facturer’s protocol (Roche, Mannheim, Germany). Angillustrated in a rat model of crescentic antiglomerular
II was purchased from Calbiochem (Melbourne, Victo-basement membrane nephritis, where neutralizing anti-
ria, Australia). Irbesartan was a gift from Bristol-Myersbodies, administered prophylactically or therapeutically,
Squibb Pharmaceuticals (Princeton, NJ, USA).reduce renal damage [29, 30].
Because Ang II has been implicated in promoting im-
In situ hybridizationmune mediated renal injury and MIF mediates leukocyte
In situ hybridization was performed on 4 m paraffinaccumulation and activation, we hypothesized that Ang
sections of formalin-fixed tissue using a modified versionII may cause renal inflammation via the production of
of a standard protocol [35]. Briefly, sections were incu-MIF by tubular epithelial cells. To evaluate this, we ex-
bated with 0.2 mol/L HCl for 20 minutes, followed byamined the effect of Ang II blockade on MIF expression
0.3% Triton X-100 for 15 minutes, and then digested forand leukocytic infiltration in rats after subtotal nephrec-
20 minutes with 10 g/mL proteinase K (Roche) at 37C.tomy (STNx). The direct effects of Ang II on MIF pro-
After fixation in 4% paraformaldehyde for 10 minutes,duction and release were determined using cultured ro-
sections were incubated for 1 hour in hybridizationdent tubular epithelial cells.
buffer, then hybridized with 0.1 ng/L DIG-labeled anti-
sense or sense MIF cRNA probe overnight at 37C. Hy-
METHODS bridization buffer contained 50% deionized formamide,
4  standard saline citrate (SSC) solution, 1 mg/mLExperimental protocol for animal study
salmon sperm DNA (Sigma, Castle Hill, NSW, Austra-Renal tissues from a previously published study were
lia), and 1 mg/mL yeast tRNA. The next day, sectionsexamined [31]. Eight-week-old Sprague-Dawley rats
were washed in 2  SSC then 0.1  SSC at 42C for 20(220 to 280 g) underwent STNx (right nephrectomy fol-
minutes, and the bound DIG-labeled probe detectedlowed by infarction of approximately two thirds of the
using AP-conjugated sheep anti-DIG F(ab) fragment,left kidney) or sham surgery (laparotomy and manipula-
and developed with the chromogenic agents, nitro bluetion of both kidneys, N  8). Rats undergoing STNx
tetrazolium (NBT) and X phosphate (Roche). Cortical
were randomly allocated to receive no drug therapy (N tubules showing a strong signal for MIF mRNA were
8) or irbesartan, an AT1RA, for 12 weeks at a dose of 15 scored by evaluating 20 high power fields (400) ran-
mg/kg per day by gavage (N  8). Animals were sacri- domly selected in the renal cortex in the animal tissues
ficed after 12 weeks following measurement of systolic and counting the percentage of MIF-positive tubules.
blood pressure, plasma creatinine, and 24-hour urinary Approximately 1000 tubules were scored for each ani-
protein and creatinine. Remnant kidneys were removed mal. Fifty glomeruli per animal were assessed and the
and fixed in 10% formalin and renal tissue examined. number of MIF mRNA cells per glomerular cross-
section (gcs) counted.Reagents
Antibodies used for immunohistochemistry were ED-1, Immunohistochemistry
mouse antirat CD68 monoclonal antibody (mAb), which Immunostaining for MIF and leukocytes was per-
labels most monocytes and macrophages [32] (Serotec, formed on 4 m formalin-fixed sections was performed
Kidlington, Oxford, UK); W3/13, mouse antirat CD43 as previously described [28, 36]. Briefly, sections for ED-1
(leucosialin) mAb, which labels T lymphocytes and some staining were microwaved in citrate buffer pH 6.0 for 12
granulocytes [33]; polyclonal rabbit anti-MIF serum [23]; minutes and then cooled on ice. Sections for MIF or
horseradish peroxidase (HRP)-and alkaline phosphatase W3/13 staining were not microwaved. Sections were
(AP)-conjugated goat antimouse IgG (Dako, Carpinteria, blocked with 10% normal sheep serum and then incu-
CA, USA); mouse or rabbit peroxidase antiperoxidase bated with ED-1, W3/13, or rabbit anti-MIF antibodies
complexes (PAP, Dako); and mouse alkaline phosphatase in 1% bovine serum albumin (BSA) overnight at 4C.
antialkaline phosphatase complexes (APAAP, Dako). The following day, endogenous peroxidase was inacti-
Mouse anti-MIF mAb (III.D.9) [28] and mouse antirat vated with 0.3% H2O2 in methanol, and then sections
CD8 mAb (OX-8) [34] were used for flow cytometry were incubated with HRP-conjugated goat antimouse or
analysis using fluorescence-activated cell sorter (FACS) antirabbit immunoglobulin G (IgG), followed by mouse
after labeling with Alexa 488 fluorescence dye (Alexa or rabbit PAP and developed with diaminobenzamide
488 Protein Labeling Kit A-10235, Molecular Probes, (Sigma) to produce a brown color. For two-color immu-
nostaining, sections were first stained for MIF as de-Eugene, Oregon, USA). A cloned 325 base pair (bp) frag-
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Fig. 1. Macrophage migration inhibitory fac-
tor (MIF) mRNA and protein expression fol-
lowing subtotal nephrectomy (STNx). MIF
expression was detected by in situ hybridiza-
tion and MIF protein by immunohistochemis-
try staining. (a ) Kidney from a sham-operated
rat showing very weak expression of MIF
mRNA in most tubules, with strong MIF
mRNA expression in a small number of tu-
bules (arrows). (b ) Kidney from a rat 12 weeks
after undergoing STNx showing strong MIF
mRNA expression in many tubules, particu-
larly dilated and damaged tubules. (c ) Kidney
from a rat 12 weeks after STNx and irbesartan
treatment showing only a small number tu-
bules with strong MIF mRNA expression
(arrows). (d ) No signal was seen in an area
of tissue damage in STNx using a MIF sense
probe. (e ) Very weak immunostaining for
MIF protein is seen in most tubules in a sham-
operated rat. ( f ) Strong MIF immunostaining
is seen in many dilated and damaged tubules
at 12 weeks after STNx. Inset shows a lack of
staining in a damaged STNx kidney using an
isotype-matched control antibody. (g ) Kidney
from a rat 12 weeks after STNx and irbesartan
treatment showing only weak tubular MIF im-
munostaining, similar to sham-operated rat.
(h ) Two-color immunostaining showing focal
interstitial accumulation of ED-1 macro-
phages (blue) in an area with damaged tubules
showing strong MIF protein staining (*),
whereas the area to the right shows only weak
tubular MIF immunostaining and no macro-
phage accumulation. Magnification (a) to (g),
160; (h), 250.
scribed above, microwaved to prevent antibody cross- cells/gcs. To assess tubulointerstitial staining, the number
of labeled interstitial cells was counted on 50 high powerreactivity [36], and then stained for macrophages using
the ED-1 antibody followed by AP-conjugated goat anti- fields (400) for each animal by means of a 0.02 mm2
mouse IgG and mouse APAAP and developed with Fast graticule fitted in the eyepiece of the microscope and
Blue BB salt (Ajax Chemicals, Melbourne, Australia) expressed as cells per mm2.
to produce a blue color.
Cell cultureThe number of ED-1 and W3/13 labeled cells was
counted under high power (400) in 25 glomeruli for A rat tubular epithelial cell line (NRK52E) was ob-
tained from the American Type Culture Collectioneach animal and was expressed as the number of labeled
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gel, then capillary blotted onto a nylon membrane (Magna
Nylon Transfer Membrane; Micron Separation, Inc., West-
borough, MA, USA). The membrane was hybridized
overnight with a DIG-labeled MIF or GAPDH cRNA
probe. Bound probes were detected with AP-conjugated
sheep anti-DIG Fab fragments (Roche) and developed
with CPD star (Roche)–enhanced chemiluminescence,
which was captured on Kodak BMR film. Densitometric
analysis used the Gel Pro Analyzer program (Media
Cybernetics, Silver Spring, MD, USA). Each experiment
contained three to five replicates of flasks. All experi-




RNA was extracted from NRK52E and MCT cells and
from normal rat and mouse kidney using TRIzol (In-
vitrogen Life Technologies, Carlsbad, CA, USA). RNA
(5g/sample) was reverse transcribed using oligo-dT(15)
and Superscript II Reverse Transcriptase (Invitrogen)
for 50 minutes at 42C. The cDNA was amplified in a
50 L PCR reaction containing 2.5 U Platinum Taq
Polymerase (Invitrogen), 50 mmol/L KCl, 1.5 mmol/L
Fig. 2. Quantification of macrophage migration inhibitory factor (MIF) MgCl2, 200 mol/L deoxynucleotide triphosphate (dNTP)mRNA expression following subtotal nephrectomy (STNx). (A ) The
mix, 25 pmol oligonucleotide primers, 20 mmol/L Tris-number of MIF mRNA cells per glomerular cross-section (gcs). (B )
The percentage of cortical tubules with strong MIF mRNA expression. HCl, pH 8.4, for 35 cycles on a GeneAmp PCR System
Sham surgery (sham), STNx, STNx  irbesartan treatment (STNx  2400 (Perkin-Elmer, Inc., Norwalk, CT, USA). Samples
Irb). Data are mean  SD. *P  0.05; ***P  0.001 by ANOVA with
were initially heated to 94C for 2 minutes and then wentBonferroni’s post-test comparison.
through 35 cycles of 94C for 30 seconds, 57C for 60
seconds, and 72C for 120 seconds, with a final extension
step at 72C for 7 minutes. The primers for mouse and
(ATCC, Manassas, VA, USA) and a mouse proximal rat AT1a were 5-agcatcatctttgtggtggg-3 and 5-ttcgtaga
tubular epithelial cell line (MCT) was a gift from Profes- caggcttgagtg-3 (accession S37484) and primers for rat
sor Eric Neilson [37]. Cells were maintained in low glu- and mouse AT1b were 5-tccaagatgactgccccaag-3 and
cose (1 g/L, NRK52E) or high glucose (4.5 g/L, MCT) 5-gttatctgaagggcggtagg-3 (accession S37491). The PCR
Dulbecco’s modified Eagle’s medium (DMEM) con- products were visualized by agarose gel electrophoresis
taining 10% fetal calf serum (FCS), 100 IU/mL penicillin- and viewed under ultraviolet illumination.
streptomycin, and 2 mmol/L glutamine in a humidified
Flow cytometryincubator at 37C.
To examine intracellular MIF protein expression,
Northern blotting NRK52E cells were starved in 0.5% FCS/DMEM for 24
Semiconfluent flasks of NRK52E cells were starved in hours in 6-well plates. Cells were then stimulated with
0.5% FCS/DMEM for 24 hours. Flasks of cells were then Ang II 10	5 mol/L for 0 minutes, 10 minutes, 20 minutes,
left unstimulated or stimulated for 6 hours with 10	5 to 1 hour, or 2 hours (some cells were treated with 10	4
10	7 mol/L Ang II with or without preincubation for 1 mol/L irbesartan for 1 hour before Ang II addition).
hour with 10	4 mol/L irbesartan. Semiconfluent flasks of After incubation, cells were removed by brief trypsiniza-
MCT cells were starved in serum-free DMEM for 24 tion, fixed in 1% paraformaldehyde for 30 minutes, and
hours, then left unstimulated or stimulated for 6 hours permeabilized with 0.1% saponin in 1% FCS/phosphate-
with 10	7 mol/L Ang II with or without preincubation buffered saline (PBS). Permeabilized cells were incu-
for 1 hour with 10	4mol/L irbesartan. bated with Alexa 488–labeled III.D.9 mouse anti-MIF
For all experiments total cellular RNA was extracted mAb or Alexa 488–labeled OX-8 mAb (control) diluted
from cell pellets using TRIzol Reagent (GIBCO BRL, in 0.1% saponin in 1% FCS/PBS for 30 minutes in the
Gaithersburg, MD, USA). Denatured RNA (15 ug) was dark at 4C. After incubation, cells were washed and
analyzed on a flow cytometer connected to a data acquisi-size fractionated by electrophoresis on a 1.2% agarose
Rice et al: Angiotensin induces MIF synthesis and secretion 1269
Fig. 3. Immunostaining of leukocytes in subtotal nephrectomy (STNx). ED-1 macrophages (gray) in the kidney of (a ) sham-operated rat, (b )
week 12 following STNx in untreated rat, and (c) week 12 following STNx in rat treated with irbesartan. W3/13  T cells (gray) in the kidney of (d)
sham-operated rat, (e) week 12 following STNx in untreated rat, and ( f) week 12 following STNx in rat treated with irbesartan. Magnification, 160.
tion system. The cells were illuminated by an argon ion point was expressed as a percentage of the unstimulated
value. Each experiment contained two to three replicateslaser and fluorescence was measured. The viable cell
population was gated from debris on the basis of forward at each time point. Three separate experiments were
performed and the combined results were analyzed.angle and 90 angle light scatter. A fluorescence histo-
gram of approximately 10,000 cells was obtained for each
Western blottingcell sample and the mean channel fluorescence (MCF)
measured. For each experiment, the average MCF was To examine intracellular MIF protein expression,
semiconfluent flasks of NRK52E and MCT cells werecalculated for unstimulated cells labeled with III.D.9 and
assigned a value of 100%. The average MCF at each time lysed in 50 mmol/LTris-HCl, pH 7.4, 150 mmol/L NaCl,
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Fig. 4. Quantification of leukocytic infiltrate following subtotal nephrectomy (STNx). The number of (A ) glomerular ED-1 macrophages, (B )
tubulointerstitial ED-1macrophages, (C ) glomerular W3/13  T cells, and (D ) tubulointerstitial W3/13  T cells. Sham surgery (sham), STNx,
STNX  irbesartan treatment (STNx  Irb). Data are mean  SD. *P  0.05; **P  0.01; ***P  0.001 by ANOVA with Bonferroni’s post-
test comparison.
1% Triton X-100, 1% deoxycholate, 0.1% sodium dode- bated with 500 L protein A sepharose gel (Amersham)
for 1 hour at 4C, then the gel was washed by centrifuga-cyl sulfate (SDS) containing a protease inhibitor cocktail
(Sigma). Cell lysates were centrifuged and the superna- tion three times in PBS. Cell culture supernatants were
then incubated with the gel for 2 hours at 4C. After wash-tants collected and loaded onto 15% polyacrylamide gels
containing SDS and run under reducing conditions. Ly- ing three times, the gel was re-suspended in SDS-poly-
acrylamide gel electrophoresis (PAGE) sample buffersate samples (approximately 50 g) were separated by
electrophoresis and then transferred to Hybond-ECL and boiled (5 minutes) to solubilize the bound MIF in
the sample buffer. The immunoprecipitated MIF wasnitrocellulose membrane (Amersham Pharmacia Bio-
tech, Castle Hill, NSW, Australia). MIF protein was de- run on a 15% polyacrylamide gels containing SDS and
detected by Western blotting as described above.tected as previously described [38]. Briefly, after blocking
in 5% skim milk powder, membranes were incubated
Statisticsfor 1 hour with rabbit anti-MIF serum (1:1000). After
washing, membranes were incubated for 1 hour in HRP- Comparisons were performed by Student t test or by
analysis of variance (ANOVA) with Bonferroni’s post-conjugated antirabbit IgG (Silenus, Melbourne, Victoria,
Australia), and MIF protein detected using an enhanced test comparison. Correlations were performed using
Pearson’s correlation coefficient. All analyses were per-chemiluminescence (ECL) detection kit (Pierce, Rock-
ford, IL, USA). Chemiluminescent emissions were cap- formed using GraphPad Prism 3.0 (GraphPad Software,
San Diego, CA, USA).tured on Kodak BMR film.
To examine MIF protein secretion, semiconfluent
NRK52E cells were starved in 0.5% FCS/DMEM for 24
RESULTS
hours in 6-well plates. Cells were then stimulated with
Irbesartan suppresses renal injury in STNx10	5 mol/L Ang II for 20 minutes or left unstimulated.
Cell culture supernatant (1 mL) was collected and con- STNx rats developed elevated systolic blood pressure,
proteinuria, and a reduced glomerular filtration ratecentrated by immunoprecipitation using anti-MIF anti-
bodies. Briefly, 50 L rabbit anti-MIF serum was incu- (GFR)—all of which were normalized by irbesartan
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Fig. 6. Irbesartan (Irb) blocks angiotensin II (Ang II) stimulation of
macrophage migration inhibitory factor (MIF) mRNA expression in
NRK52E cells. (A ) Northern blot in which NRK52E cells were either
left unstimulated (Nil), stimulated with 10	6 or 10	7 mol/L Ang II for
6 hours or incubated with 10	4 mol/L Irb for 1 hour prior to stimulation
with Ang II 10	6 mol/L (Irb  Ang 10	6) for 6 hours. Blots were
probed for MIF and then reprobed for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). (B ) Results of densitometric analysis of the
combined results of three experiments are shown. Data are mean 
SD. **P  0.01 by ANOVA with Bonferroni’s post-test comparison.
ated rats, with a small number of tubules showing a strong
signal for MIF mRNA. The percentage of tubules with
strong MIF mRNA expression increased from 5.4% 
1.1% (mean  SD) in sham-operated rats to 44.9% 
22.6% in STNx rats but was prevented by daily adminis-
tration of irbesartan (Figs. 1 and 2). Only a few glomeru-
Fig. 5. Angiotensin II (Ang II) stimulates macrophage migration inhib- lar cells expressed MIF mRNA, which increased nearly
itory factor (MIF) mRNA expression in NRK52E cells. (A ) Northern twofold in STNx rats. Irbesartan prevented the increase
blot in which NRK52E cells were either left unstimulated (Nil) or
in MIF mRNA expression in the glomerulus (Figs. 1 andstimulated with 10	5 mol/L Ang II for 6 hours. Blots were probed for
MIF and then reprobed for glyceraldehyde-3-phosphate dehydrogenase 2). Interstitial cells also expressed MIF mRNA following
(GAPDH). (B ) Results of densitometric analysis of the combined re- STNx.
sults of three experiments are shown. Data are mean  SD. ***P 
0.001 by Student t test.
Macrophage and T-cell infiltrate
Significant infiltration of ED-1 macrophages and
W3/13 T cells into the glomerulus and tubulointerstit-treatment [31]. STNx rats developed glomerular changes,
ium was evident in STNx rats (Figs. 3 and 4). Two-colorconsisting of hyalinosis or sclerosis, and tubulointerstitial
immunostaining showed that interstitial macrophage ac-damage, consisting of inflammation, fibrosis, tubular at-
cumulation was mainly localized to areas with strongrophy, and dilatation, as well as cast formation. Both
tubular MIF expression (Fig. 1h). Treatment with irbe-glomerulosclerosis and tubulointerstitial damage were
sartan completely ameliorated the leukocytic infiltratesignificantly reduced by irbesartan treatment [31]. Sham-
(Figs. 3 and 4). The number of glomerular MIF mRNAoperated animals were not different to normal controls.
cells correlated with glomerular macrophage (r 2  0.80,
MIF mRNA expression P 0.0001) and T-cell infiltration (r 2 0.71, P 0.0001).
In addition, the percentage of tubules with strong MIFIn situ hybridization revealed very weak MIF mRNA
expression in most tubular epithelial cells in sham-oper- mRNA expression correlated with interstitial macro-
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Fig. 8. NRK52E and MCT express the angiotensin II (Ang II) receptor
1a subtype (ATR1a). RNA was extracted from NRK52E and MCT
cells, reverse transcribed and then ATR1a detected by polymerase chain
reaction (PCR). A single band of the expected 893 bp for ATR1a was
detected in both cell lines. Positive controls were normal mouse and
rat kidney. Negative control omitted the reverse transcripton (RT)
product. DNA markers of 800, 1200, and 2000 bp are shown.
Fig. 7. Angiotensin II (Ang II) stimulates macrophage migration inhib-
itory factor (MIF) mRNA expression in MCT cells, which is blocked
by irbesartan (Irb). (A ) Northern blot in which MCT cells were either
left unstimulated (Nil), stimulated with 10	7 mol/L Ang II or incubated
with 10	4 mol/L Irb for 1 hour prior to stimulation with 10	7 mol/L
Ang II (Irb  Ang 10	7) for 6 hours. Blots were probed for MIF and Fig. 9. Constitutive macrophage migration inhibitory factor (MIF) pro-
then reprobed for glyceraldehyde-3-phosphate dehydrogenase (GAPDH). tein expression by tubular epithelial cell lines. Western blotting of MCT
(B ) Results of densitometric analysis of the combined results of 3 and NRK52E cell lysates demonstrates constitutive expression of a
experiments are shown. Data are mean  SD. *P  0.05; **P  0.01, protein band at 12.5 kD that corresponds in size to recombinant human
by ANOVA with Bonferroni’s post-test comparison. MIF (Rec MIF).
Ang II induces secretion of MIF in vitrophage (r 2  0.35, P  0.01) and T-cell infiltration (r 2 
0.22, P  0.05). Analysis by Western blotting and flow cytometry re-
vealed that unstimulated NRK52E and MCT cells con-
Ang II induces up-regulation of MIF mRNA in vitro tain MIF protein (Figs. 9 and 10). Stimulation of NRK-
52E cells with Ang II 10	5 mol/L caused rapid secretionThe ability of irbesartan to prevent up-regulation of
(within 20 minutes) of approximately 50% of MIF pro-tubular MIF expression in STNx could be due to a direct
tein stores from cells as shown by a loss of intracellulareffect of Ang II on MIF gene expression, or an indirect
MIF protein staining detected by flow cytometry. Levelseffect of suppression of renal injury. Therefore, we exam-
of intracellular MIF returned to baseline over the nextined whether Ang II has a direct effect on MIF expres-
2 hours (Fig. 10). Addition of irbesartan prevented Angsion by studying tubular epithelial cells in vitro. Cultured
II–induced MIF secretion by NRK52E cells (Fig. 10).NRK52E tubular epithelial cells constitutively express
Confirmation of MIF secretion from NRK52E cells wasMIF mRNA. Ang II (10	5 or 10	6 mol/L) increased MIF
performed by detection of increased amounts of MIFmRNA levels twofold within 6 hours and could be pre-
in the cell culture media by immunoprecipitation andvented by prior addition of 10	4 mol/L irbesartan. 10	7
Western blotting. This showed that MIF is constitutivelymol/L Ang II did not cause an increase in expression of
secreted by NRK52E cells and that stimulation with Ang
MIF mRNA (Figs. 5 and 6). These findings were con-
II for 20 minutes caused increased accumulation of MIF
firmed in a second tubular cell line. MCT cells were also protein in the media (Fig. 11).
shown to constitutively express MIF mRNA and the
addition of 10	7 mol/L Ang II doubled MIF mRNA
DISCUSSIONlevels. This effect was also completely prevented by pre-
incubation with 10	4 mol/L irbesartan (Fig. 7). PCR anal- The RAS has a pathogenic role in immune- and non-
ysis showed that both NRK52E and MCT cell lines ex- immune-mediated renal diseases in humans and experi-
mental models. Some of the beneficial effects of Ang IIpress the Ang II receptor 1a subtype (Fig. 8).
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Fig. 11. Secretion of MIF protein by NRK52E cells is increased by
angiotensin II. Macrophage migration inhibitory factor (MIF) was im-
munoprecipitated from the supernatant of unstimulated (Nil) NRK52E
cells or NRK52E cells stimulated with 10	5 mol/L angiotensin II (Ang II)
for 20 minutes, and then detected by Western blotting using a MIF anti-
body. This revealed secretion of a 12.5 kD protein by NRK52E cells
that was the same size as recombinant human MIF protein (Rec MIF).
these effects on leukocytes are a direct effect of Ang II
or whether they occur through induction of other proin-
flammatory molecules. This study provides evidence that
Ang II–mediated macrophage and T-cell accumulation
and activation may occur indirectly through MIF.
STNx in rats is a model of progressive renal injury
characterized by infiltration of macrophages into the glo-
merulus and interstitium that leads to secondary focal
and segmental glomerulosclerosis and tubulointerstitial
damage [41, 42]. In the STNx model, there is local activa-
tion of the RAS within the kidney with evidence of de
novo expression of renin and Ang II in tubules. There
are several studies showing reversal of leukocyte infil-
trate and renal damage in this disease model by the use
of ACEI or AT1RA [43–45]. We hypothesized that local
activation of the tubular RAS plays a central role in
inducing increased expression of MIF that results in leu-
kocyte-mediated renal injury.
In this study we showed that MIF mRNA was up-
regulated in tubular and glomerular epithelial cells fol-
lowing STNx. Blockade of the RAS with irbesartan, an
AT1RA, reduced MIF mRNA expression in tubular and
glomerular epithelial cells. Reduction in MIF expression
correlated with reduced macrophage and T-cell infiltrate,
suggesting that Ang II may stimulate renal injury indi-
rectly through MIF.
The up-regulation of MIF expression in this model
may be due to a direct effect of Ang II or an indirect effect
through the action of other factors such as hypertension.
Therefore, to examine the relationship between Ang IIFig. 10. Flow cytometry analysis of intracellular macrophage migration
inhibitory factor (MIF) protein. NRK52E cells were stimulated with 10	5 and MIF, we performed in vitro experiments in two
mol/L angiotensin II (Ang II) for various periods, fixed, permeabilized, tubular epithelial cell lines. We found that Ang II dou-and labeled with Alexa 488–conjugated OX-8 (Control Ab) or Alex-conju-
bled MIF mRNA expression and this could be preventedgated IIID9 (MIF Ab). (A ) Histograms from one experiment show base-
line MIF expression (MIF Ab) compared to the negative control antibody by irbesartan. This provided evidence that the proin-
(Control Ab). Twenty minutes after Ang II stimulation there is a marked
flammatory activities of Ang II may be mediated throughreduction in MIF protein within the cells, which is largely prevented by
the presence of 10	4 mol/L irbesartan. (B) The combined results of three the induction of MIF synthesis in renal tubular epithelial
separate experiments. Data are mean  SD. *P  0.05 vs. unstimulated cells via activation of the Ang II type I receptor.cells by ANOVA with Bonferroni’s post-test comparison.
Local, rather than systemic production, of both Ang
II and MIF by the kidney is important in renal disease.blockade by ACEI or AT1RA are independent of blood
Dissociation between intrarenal and plasma Ang II lev-pressure control. Ang II regulates a variety of inflamma-
els has been shown in several animal models such astory cell responses, including mononuclear cell chemo-
STNx [46], two-kidney, one clip Goldblatt hypertensiontaxis [10, 39] and proliferation [40], as well as cytokine
production by inflammatory cells [6]. It is unknown if [47], Ang II–induced hypertension [48], and hyperten-
Rice et al: Angiotensin induces MIF synthesis and secretion1274
sive ren-2 transgenic rats [49]. Similarly, serum MIF lev- secretion may be an important mechanism by which Ang
II recruits and activates inflammatory cells, which resultsels are not elevated in humans with glomerulonephritis
or renal transplant rejection while immunohistochemis- in renal damage.
try reveals up-regulation of MIF in the kidney [50, 51].
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